Link here: Adherium Limited is pleased to announce that its UK value-add distribution partner, Helicon Health Ltd, has been awarded a prestigious 3 year Fellowship on the 2023 NHS Innovation Accelerator (NIA), to boost their new Director of Operations, Sander Ten Veldhuijs, in scaling the Hailie® Digital Inhaler solution across NHS England.
The NIA programme involves a rigorous, multi-stage application and assessment process that includes evaluation by a panel of clinical, patient, and commercial assessors, and we are proud that both Sander and the Hailie Solution, have been selected to help address the unmet needs of Asthma and COPD patients.
“This achievement is a testament to Sander and his team’s hard work and dedication and represents another key milestone in the UK Market Access for Adherium’s Hailie solution. We extend our warmest congratulations to Sander and his colleagues at Helicon,” commented Francis White, VP Global Business Development, Adherium.
“The NHS Innovation Accelerator’s active support for innovative solutions like Hailie, championed by a high-calibre professional such as Sander Ten Veldhuijs, is truly aweinspiring. As a proud alumnus of the Programme myself, I have personally witnessed the incredible level of backing and resources provided to accelerate adoption and improve patient activation.”
“It’s heartening to see the NHS prioritise advancements that not only reduce healthcare costs but also enhance patient outcomes and overall quality of care. This is a shining example of how the NHS, in partnership with industry, can push the boundaries of innovation to improve lives and transform the future of healthcare.” Tony Bowden, CEO, Helicon Health Ltd.
The Hailie Digital Inhaler is a Bluetooth-based medication adherence solution that utilises sensors attached to regular inhalers, providing patients with real-time feedback via the Hailie app, and clinicians with secure access to patient data through a web portal. Helicon Health provide the full service to ensure successful deployment such as advanced patient finding, business case development, pathway redesign and customer support.
The NIA program, commissioned by the NHS Accelerated Access Collaborative, is an award-winning NHS England initiative that accelerates the uptake of promising innovations to benefit patients, populations, and NHS staff in line with the NHS Long Term Plan priorities. It is delivered in partnership with the 15 Academic Health Science Networks (AHSNs) and hosted by UCLPartners.